Dan Perry on BioCentury This Week: Alzheimer's Research
|Date:||March 18, 2012|
|Related Topics:||Alzheimer's Disease Drug Development Federal Funding Policy Research|
In a March 18th interview with BioCentury This Week, Alliance for Aging Research President & CEO Daniel Perry shares his thoughts on U.S. funding of Alzheimer’s research. Perry also calls for the U.S. Food and Drug Administration to adopt biomarkers and other tools to detect and treat Alzheimer's disease earlier.
Living Longer and Loving It!
Sign up for the Alliance's quarterly newsletter and get timely information on advancements in science, treatment, and health policy that help you "Live Longer and Love It."